Marquette K A, Pittman D D, Kaufman R J
Genetics Institute, Cambridge, MA, USA.
Blood. 1995 Oct 15;86(8):3026-34.
Blood coagulation factors V and VIII are homologous proteins that have the domain organization A1-A2-B-A3-C1-C2. Upon thrombin activation, the B-domains of both molecules are released. Previous studies on factor VIII showed that the B-domain was not required for thrombin cleavage or activity. In contrast, deletion of the factor V B-domain (residues 709 to 1545) yielded a molecule with sevenfold reduced procoagulant activity that was not cleaved by thrombin. However, this factor V B-domain deletion molecule was activated by factor Xa, although the fold-activation was 85% that of wild-type factor V. Thrombin cleavage of factor V occurs initially after residue 709 and subsequently after residues 1018 and 1545. The requirement for thrombin cleavage within the B-domain at residue 1018 was evaluated by mutagenesis of Arg1018 to Ile. In the resultant R1018I mutant, the rate of thrombin activation and appearance of maximal cofactor activity was delayed and was consistent with delayed cleavage of the light chain at residue 1545. In contrast, the rate of factor Xa activation in the R1018I mutant was not altered. This finding suggests that thrombin cleavage at 1018 facilitates subsequent thrombin cleavage at 1545. Further mutagenesis was used to study the requirement for sequences within the factor V B-domain for thrombin cleavage at residue 1545. Whereas the factor V deletion molecule removing residues 709 to 1545 was not cleaved by thrombin, a smaller B-domain deletion molecule (residues 709 to 1476) containing an acidic amino acid-rich region (residues 1490 to 1520) was effectively cleaved by thrombin. These results show that residues 1476 to 1545, which contain an acidic amino acid-rich region, were required for thrombin cleavage of the light chain. Introduction of an acidic amino acid-rich region from factor VIII (residues 337 to 372) into the factor V 709 to 1545 deletion also restored thrombin cleavage of the light chain. In contrast, similar replacement with the acidic region from the factor VIII light chain (residues 1649 to 1689) was significantly less effective in promoting thrombin cleavage of the light chain. This finding suggests that the different acidic regions in factors V and VIII are not functionally equivalent in their interaction with thrombin.(ABSTRACT TRUNCATED AT 400 WORDS)
凝血因子V和VIII是同源蛋白,具有A1-A2-B-A3-C1-C2结构域组织。经凝血酶激活后,这两种分子的B结构域均被释放。先前对因子VIII的研究表明,B结构域对于凝血酶切割或活性并非必需。相比之下,删除因子V的B结构域(第709至1545位氨基酸残基)产生了一种促凝活性降低7倍的分子,该分子不能被凝血酶切割。然而,这种因子V B结构域缺失分子可被因子Xa激活,尽管激活倍数为野生型因子V的85%。因子V的凝血酶切割最初发生在第709位氨基酸残基之后,随后发生在第1018和1545位氨基酸残基之后。通过将Arg1018突变为Ile来评估B结构域中第1018位氨基酸残基处凝血酶切割的必要性。在所得的R1018I突变体中,凝血酶激活速率和最大辅因子活性的出现延迟,这与轻链在第1545位氨基酸残基处的切割延迟一致。相比之下,R1018I突变体中因子Xa的激活速率未改变。这一发现表明,第1018位氨基酸残基处的凝血酶切割促进了随后第1545位氨基酸残基处的凝血酶切割。进一步的诱变用于研究因子V B结构域内序列对于第1545位氨基酸残基处凝血酶切割的必要性。虽然删除第709至1545位氨基酸残基的因子V缺失分子不能被凝血酶切割,但一个较小的B结构域缺失分子(第709至1476位氨基酸残基),其包含一个富含酸性氨基酸的区域(第1490至1520位氨基酸残基),可被凝血酶有效切割。这些结果表明,包含富含酸性氨基酸区域的第1476至1545位氨基酸残基是轻链凝血酶切割所必需的。将因子VIII的富含酸性氨基酸区域(第337至372位氨基酸残基)引入因子V第709至1545位氨基酸残基的缺失区域也恢复了轻链的凝血酶切割。相比之下,用因子VIII轻链的酸性区域(第1649至1689位氨基酸残基)进行类似替换在促进轻链凝血酶切割方面效果明显较差。这一发现表明,因子V和VIII中不同的酸性区域在与凝血酶相互作用时功能并不等同。(摘要截断于400字)